Correlation Between Prime Medicine, and Innovator Loup

Can any of the company-specific risk be diversified away by investing in both Prime Medicine, and Innovator Loup at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine, and Innovator Loup into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Prime Medicine, Common and Innovator Loup Frontier, you can compare the effects of market volatilities on Prime Medicine, and Innovator Loup and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine, with a short position of Innovator Loup. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine, and Innovator Loup.

Diversification Opportunities for Prime Medicine, and Innovator Loup

0.17

Correlation Coefficient

Prime Medicine,  Innovator Loup

Average diversification

The 3 months correlation between Prime and Innovator is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and Innovator Loup Frontier in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Loup Frontier and Prime Medicine, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine, Common are associated (or correlated) with Innovator Loup. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Loup Frontier has no effect on the direction of Prime Medicine, i.e., Prime Medicine, and Innovator Loup go up and down completely randomly.

Pair Corralation between Prime Medicine, and Innovator Loup

Given the investment horizon of 90 days Prime Medicine, Common is expected to under-perform the Innovator Loup. In addition to that, Prime Medicine, is 2.36 times more volatile than Innovator Loup Frontier. It trades about -0.07 of its total potential returns per unit of risk. Innovator Loup Frontier is currently generating about -0.07 per unit of volatility. If you would invest  5,705  in Innovator Loup Frontier on December 5, 2024 and sell it today you would lose (587.00) from holding Innovator Loup Frontier or give up 10.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Prime Medicine, Common  vs.  Innovator Loup Frontier

Prime Medicine, Common

Risk-Adjusted Performance

Very Weak

Over the last 90 days Prime Medicine, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's primary indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the fund shareholders.

Innovator Loup Frontier

Risk-Adjusted Performance

Very Weak

Over the last 90 days Innovator Loup Frontier has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unfluctuating performance, the Etf's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the ETF retail investors.

Pair Trading with Prime Medicine, and Innovator Loup

The main advantage of trading using opposite Prime Medicine, and Innovator Loup positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine, position performs unexpectedly, Innovator Loup can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Loup will offset losses from the drop in Innovator Loup's long position.

The idea behind Prime Medicine, Common and Innovator Loup Frontier pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.